Specifically, VPS35 promotes the sorting and trafficking of transmembrane receptor, thereby augmenting the proliferation of hepatoma cell through the PI3K/AKT signaling pathway (Zhang et al. 2020). Here, VPS35 is linked to hepatocellular carcinoma.